Skip to main content

Advertisement

Table 1 Baseline characteristics of all 118 patients

From: Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy - Long-term results

Age median/range (years) 64/30 - 84
Female/male no. 35/83
Clinical tumor stage no. (%)  
cT2 11 (9.3)
cT3 106 (89.3)
cT4 1 (0.8)
Clinical nodal stage no. (%)  
Node negative 60 (50,8)
Node positive 54 (45.8)
Unknown 4 (3.4)
Clinical UICC stage no. (%)  
II 59 (50)
III 49 (41.5)
IV 10 (8.5)
Tumor location no. (%)  
Upper third of rectum 10 (8.5)
Middle third of rectum 59 (50)
Lower third of rectum 49 (41.5)